Background Both epilepsy and paragonimiasis had been known to be endemic in Southwest Cameroon. A total of 188 people (168 and 20 with and without symptoms confirmed by clinicians, respectively, 84.6% under 20 years old) were selected on a voluntary basis. Among 14 people (8.3%) with history of epilepsy, only one suffered from paragonimiasis. Therefore, we challenged to check antibody responses to highly specific diagnostic recombinant antigens for two other helminthic diseases, cysticercosis and toxocariasis, expected to be involved in neurological diseases. Soil-transmitted helminthic infections were also examined. Methodology/Principal Findings Fecal samples were collected exclusively from the 168 people. Eggs of Ascaris lumbricoides, Trichuris trichiura and hookworms were found from 56 (33.3%), 72 (42.8%), and 19 (11.3%) persons, respectively. Serology revealed that 61 (36.3%), 25 (14.9%) and 2 (1.2%) of 168 persons showed specific antibody responses to toxocariasis, paragonimiasis and cysticercosis, respectively. By contrast, 20 people without any symptoms as well as additional 20 people from Japan showed no antibody responses. Among the 14 persons with epilepsy, 5 persons were seropositive to the antigen specific to Toxocara, and one of them was simultaneously positive to the antigens of Paragonimus. The fact that 2 children with no history of epilepsy were serologically confirmed to have cysticercosis strongly suggests that serological survey for cysticercosis in children is expected to be useful for early detection of asymptomatic cysticercosis in endemic areas. Conclusions/Significance Among persons surveyed, toxocariasis was more common than paragonimiasis, but cysticercosis was very rare. However, the fact that 2 children were serologically confirmed to have cysticercosis was very important, since it strongly suggests that serology for cysticercosis is useful and feasible for detection of asymptomatic cysticercotic children in endemic areas for the early treatment.
Garcia HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, et al. (2004) A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 350: 249–258. doi: 10.1056/NEJMoa031294
Nguekam JP, Zoli AP, Zogo PO, Kamga AC, Speybroeck N, et al. (2003) A seroepidemiological study of human cysticercosis in West Cameroon. Trop Med Int Health 8: 144–149. doi: 10.1046/j.1365-3156.2003.01000.x
Nkouawa A, Okamoto M, Mabou AK, Edinga E, Yamasaki H, et al. (2009) Paragonimiasis in Cameroon: molecular identification, serodiagnosis and clinical manifestations. Trans R Soc Trop Med Hyg 103: 255–261. doi: 10.1016/j.trstmh.2008.09.014
Esum M, Wanji S, Tendongfor N, Enyong P (2001) Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin. Trans R Soc Trop Med Hyg 95: 673–676. doi: 10.1016/S0035-9203(01)90112-9
Yamasaki H, Araki K, Lim PK, Zasmy N, Mak JW, et al. (2000) Development of a highly specific recombinant Toxocara canis second-stage larva excretory-secretory antigen for immunodiagnosis of human toxocariasis. J Clin Microbiol 38: 1409–1413.
Sato MO, Sako Y, Nakao M, Yamasaki H, Nakaya K, et al. (2006) Evaluation of purified Taenia solium glycoproteins and recombinant antigens in the serologic detection of human and swine cysticercosis. J Infect Dis 194: 1783–1790. doi: 10.1086/509262
Sudewi AAR, Wandra T, Artha A, Nkouawa A, Ito A (2008) Taenia solium cysticercosis in Bali, Indonesia: serology and mtDNA analysis. Trans R Soc Trop Med Hyg 102: 96–98. doi: 10.1016/j.trstmh.2007.06.018
Yamasaki H, Taib R, Watanabe Y, Mak JW, Zasmy N, et al. (1998) Molecular characterization of a cDNA encoding an excretory-secretory antigen from Toxocara canis second-stage larvae and its application to the immunodiagnosis of human toxocariasis. Parasitol Int 47: 171–181. doi: 10.1016/s1383-5769(98)00016-6
De Andrade Lima Coelho R, De Carvalho LB Jr, Perez EP, Araki K, Takeuchi T, et al. (2005) Prevalence of toxocariasis in northeastern Brazil based on serology using recombinant Toxocara canis antigen. Am J Trop Med Hyg 72: 103–107.
Fernando SD, Wickramasinghe VP, Kapilananda GM, Devasurendra RL, Amarasooriya JD, et al. (2007) Epidemiological aspects and risk factors of toxocariasis in a pediatric population in Sri Lanka. Southeast Asian J Trop Med Public Health 38: 983–990.
Sviben M, Cavlek TV, Missoni EM, Galinovic GM (2009) Seroprevalence of Toxocara canis infection among asymptomatic children with eosinophilia in Croatia. J Helminthol 83: 1–3. doi: 10.1017/S0022149X08912402
Schantz PM, Wilkins PP, Tsang VCW (1998) Immigrants, imaging, and immunoblots: the emergence of neurocysticercosis as a significant public health problem. In: Scheld WM, Craig WA, Hughes JM, editors. Emerging Infection 2. Washington, USA: AMS. pp. 213–242.
Ito A, Takayanagui OM, Sako Y, Sato MO, Odashima NS, et al. (2006) Neurocysticercosis: clinical manifestation, neuroimaging, serology and molecular confirmation of histopathologic specimens. Southeast Asian J Trop Med Public Health 37: Suppl(3)74–81.
Nkouawa A, Sako Y, Nakao M, Nakaya K, Ito A (2009) Loop-mediated isothermal amplification method for differentiation and rapid detection of Taenia species. J Clin Microbiol 47: 168–174. doi: 10.1128/JCM.01573-08